Knowledge graph · Drug
Zoledronic Acid
small molecule
- Identifier
- CI-DRUG-00000654
- Entity page
- /drug/zoledronic-acid ↗
- Edges
- 280
- Neighbours
- 25 cancers1 genes1 variants10 trials13 approvals
- Drawn
- 50 of 50 neighbours (cap 60); table lists every fetched edge
Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.
Most connectedLung Non-Small Cell Carcinoma 3,149Malignant Colorectal Neoplasm 1,866ABL1 298EGFR 276Imatinib 450Dasatinib 321
Neighbourhood
Radial view
Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.
Edges
Every edge, grouped by relationship
Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.
| Relationship | Neighbour | Direction | Evidence level | Cancer context | Support | Claim | Source | Expand |
|---|---|---|---|---|---|---|---|---|
| Zoledronic Acid approved for …APPROVED_FOR14 of 13 | ||||||||
| → approved for | Paget Diseasehistology | supports | FDA ORIG | Paget Disease | 1 | Regulatory | openfda | graph → |
| → approved for | EMA · EU · 2014Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone. Treatment of adult patients with tumour-induced hypercalcaemia (TIH). | |||||||